Kluytmans, J.A.J.W. (Jan), Goessens, W.H.F. (Wil), Mouton, J.W. (Johan), Rijsoort-Vos, J.H. van, Niesters, H.G.M. (Bert), Quint, W.G.V. (Wim), Habbema, L., Stolz, E. (Ernst), Wagenvoort, J.H., Kluytmans, J.A.J.W. (Jan), Goessens, W.H.F. (Wil), Mouton, J.W. (Johan), Rijsoort-Vos, J.H. van, Niesters, H.G.M. (Bert), Quint, W.G.V. (Wim), Habbema, L., Stolz, E. (Ernst), and Wagenvoort, J.H.
The Clearview Chlamydia test (CV; Unipath Ltd., Bedford, United Kingdom), the Magic Lite Chlamydia test (ML; CIBA Corning, Medfield, Mass.), a polymerase chain reaction (PCR), and cell culture (CC) were evaluated for detection of Chlamydia trachomatis in urogenital specimens. Specimens were collected from 283 men and 724 women visiting the outpatient clinic for Sexually Transmitted Diseases at the University Hospital Rotterdam, Rotterdam, The Netherlands. ML, PCR, and CC were all performed on the same sample to prevent swab-to-swab variability. CV was performed on a separate sample. Analysis of discordant results was performed by application of the following confirmatory assays: first, PCR on the